Hikma And Adalvo Ally On Nasal Spray For MENA
Licensing Deal For ‘High-Value’ Product Follows Hikma’s US Ryaltris Launch
Hikma and Adalvo have struck a licensing deal that will see Hikma commercialize a “high value” nasal spray treatment for allergic rhinitis in the MENA region.
